擅長： 肺癌、胸腺癌、胸膜間皮瘤等胸部腫瘤的早期診斷、以內科化療為主的綜合規范化治療、分子靶向治療及生物治療

簡介： 本科畢業于中山醫科大學，2005年獲得北京大學醫學部腫瘤學博士學位，胸部腫瘤內一科 主任醫師，副教授，科室副主任，內科教研室常務副主任。CSCO青年專家委員會肺癌專業組委員、CSCO會員、ASCO會員。，2010年赴美國馬里蘭大學接受博士后培訓兩年，開展新型抗體治療的臨床前期動物模型研究以及腫瘤分子生物學和肺癌個體化治療的學習。目前主要從事肺癌多學科綜合治療，擅長肺癌、胸腺癌、胸膜間皮瘤等胸部腫瘤的早期診斷、以內科化療為主的綜合規范化治療、分子靶向治療及生物治療，對生物標志物指導下的肺癌個體化治療有深入研究，熟練掌握肺癌的最新國際診療規范，參加20余項國際、國內多中心臨床研究，及時掌握國際肺癌診治前沿新動向。專業特長從事腫瘤臨床工作近14年，在胸部腫瘤尤其是肺癌的多學科綜合治療上有豐富經驗及深厚的學術造詣，擅長肺癌早期診斷以及規范化、個體化多學科綜合治療及氣管鏡、TBNA、內科胸腔鏡等局部治療及操作。研究成果2008年獲得北京腫瘤醫院北京市腫瘤防治研究所所內基金，先后獲得教育部科技成果二等獎、華夏科技成果二等獎及北京市科技進步三等獎、中華醫學獎三等獎等獎勵。主要論著1) MeinaWua, Jun Zhao(equal contribution）, SonyaWei Song, Minglei Zhuo, XinWang, Hua Bai, ShuhangWanga, Lu Yang, Tongtong An, Yan Zhang, Jianchun Duan, YuyanWang, Qingzhi Guo,Xuyi Liu, Ninghong Liu, JieWang. Plasma EGFR mutations are not associated with response to first-line chemotherapy but with prognosis in the Chinese patients with advanced non-small cell lung cancer. lung cancer 2010, 67(3):343-3472) Jun Zhao, Zhi-jie Wang, Jian-chun Duan, Qing-zhi Guo, Hua Bai, Lu Yang, Tong-tong An, Xin Wang, Yu-yan Wang and Mei-na Wu, et al. A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression. Chinese journal of cancer research, 2009，21(1)： 1-12.3) Xin Wang, Jun Zhao, Lu Yang, Li Mao,Tongtong An, Hua Bai,Shuhang Wang ,Xuyi Liu,Guo shuang Feng, Jie Wang. Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer. Med Oncol 2010,27(2):484-4904) Hua Bai, Zhijie Wang, Keneng Chen, Jun Zhao, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang1, Xiaozheng Kang, Jie Wang. Influence of Chemotherapy on EGFR Mutation Status for Patients with Non-small Cell Lung Cancer. J Clin Oncol，20125) Shuhang Wang, Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, and Meina Wu.Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced NSCLC. Clin Cancer Res 2010, 15,16(4):1324-13306) 趙軍，劉敘儀，張青云，蔣薇。晚期非小細胞肺癌外周血VEGF和BFGF及MMP-9水平與預后的關系。中華腫瘤雜志 2005; 27: 676-6797) 白樺,趙軍,王書航,安彤同,王鑫,吳梅娜,段建春,楊鷺,郭慶志,劉寧紅,王潔.變性高效液相色譜法檢測非小細胞肺癌人群外周血和配對腫瘤組織EGFR突變。中華結核和呼吸雜志，2008，31：891-8968) Wu M, Wang Y, An T, Zhao J, Yang L, Duan J, Wang Z, Zhuo M, Bai H, Liu X, Wang J. Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer. Zhong guo Fei Ai Za Zhi. 2011 Mar;14(3):245-509) Wang Z, Yang L, An T, Zhao J, Bai H, Duan J, Wu M, Zhou M, Wang Y, Wang J. The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis. Zhong guo Fei Ai Za Zhi. 2009 Dec 20;12(12):1247-54.10) Yang L, Lu QY, Wu MN, An TT, Zhao J, Guo QZ, Duan JC, Wang J. A retrospective analysis: comparison of the clinical characteristics and prognosis in elderly and young patients with locally advanced or metastatic non-small cell lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):830-4.11) Wang J, Lu C, Liu XY, Zhang HB, Zhao J, Yang L, Guo QZ, An TT, Wu MN. Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):103-7